Myokines mediate the cross talk between skeletal muscle and other organs

W Chen, L Wang, W You, T Shan - Journal of cellular …, 2021 - Wiley Online Library
Myokines are muscle‐derived cytokines and chemokines that act extensively on organs and
exert beneficial metabolic functions in the whole‐body through specific signal networks …

Endothelial cell–cardiomyocyte crosstalk in heart development and disease

A Colliva, L Braga, M Giacca… - The Journal of …, 2020 - Wiley Online Library
The crosstalk between endothelial cells and cardiomyocytes has emerged as a requisite for
normal cardiac development, but also a key pathogenic player during the onset and …

[HTML][HTML] Endothelial dysfunction in heart failure with preserved ejection fraction: what are the experimental proofs?

L Cornuault, P Rouault, C Duplàa, T Couffinhal… - Frontiers in …, 2022 - frontiersin.org
Heart failure with preserved ejection fraction (HFpEF) has been recognized as the greatest
single unmet need in cardiovascular medicine. Indeed, the morbi-mortality of HFpEF is high …

[HTML][HTML] Apelin/Elabela-APJ: a novel therapeutic target in the cardiovascular system

W Liu, J Yan, W Pan, M Tang - Annals of Translational Medicine, 2020 - ncbi.nlm.nih.gov
Apelin and Elabela (ELA) are endogenous ligands of angiotensin domain type 1 receptor-
associated proteins (APJ). Apelin/ELA-APJ signal is widely distributed in the cardiovascular …

Apelin pathway in cardiovascular, kidney, and metabolic diseases: Therapeutic role of apelin analogs and apelin receptor agonists

AA de Oliveira, A Vergara, X Wang, JC Vederas… - Peptides, 2022 - Elsevier
The apelin/apelin receptor (ApelinR) signal transduction pathway exerts essential biological
roles, particularly in the cardiovascular system. Disturbances in the apelin/ApelinR axis are …

The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders

E Marsault, C Llorens‐Cortes, X Iturrioz… - Annals of the New …, 2019 - Wiley Online Library
The apelinergic pathway has been generating increasing interest in the past few years for its
potential as a therapeutic target in several conditions associated with the cardiovascular and …

The therapeutic potentials of apelin in obesity-associated diseases

I Castan-Laurell, C Dray, P Valet - Molecular and Cellular Endocrinology, 2021 - Elsevier
Apelin, a peptide with several active isoforms ranging from 36 to 12 amino acids and its
receptor APJ, a G-protein-coupled receptor, are widely distributed. However, apelin has …

[HTML][HTML] Loss of apelin augments angiotensin II-induced cardiac dysfunction and pathological remodeling

T Sato, A Kadowaki, T Suzuki, H Ito… - International journal of …, 2019 - mdpi.com
Apelin is an inotropic and cardioprotective peptide that exhibits beneficial effects through
activation of the APJ receptor in the pathology of cardiovascular diseases. Apelin induces …

A first-in-human study of AMG 986, a novel apelin receptor agonist, in healthy subjects and heart failure patients

P Winkle, S Goldsmith, MJ Koren, S Lepage… - … Drugs and Therapy, 2023 - Springer
Purpose AMG 986 is a novel apelin receptor (APJ) agonist that improves cardiac contractility
in animal models without adversely impacting hemodynamics. This phase 1b study …

[HTML][HTML] Stretch-induced biased signaling in angiotensin II type 1 and apelin receptors for the mediation of cardiac contractility and hypertrophy

K Seo, VN Parikh, EA Ashley - Frontiers in physiology, 2020 - frontiersin.org
The myocardium has an intrinsic ability to sense and respond to mechanical load in order to
adapt to physiological demands. Primary examples are the augmentation of myocardial …